# Medexus Pharmaceuticals Inc. (MEDXF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MEDXF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 99.43M | $ -272.0K | $ 17.16M | $ 25.35M | $ 52.21M |
| 2024 | $ 111.62M | $ 3.63M | $ 20.86M | $ 39.91M | $ 33.10M |
| 2023 | $ 120.08M | $ 6.10M | $ 21.53M | $ 52.29M | $ 29.56M |
| 2022 | $ 106.99M | $ -11.72M | $ -3.62M | $ 65.66M | $ 15.43M |
| 2021 | $ 81.30M | $ -8.16M | $ -19.24M | $ 53.00M | $ 23.14M |
| 2020 | $ 92.82M | $ -23.45M | $ -1.55M | $ 50.57M | $ 4.31M |
| 2019 | $ 56.52M | $ -4.70M | $ -2.13M | $ 20.18M | $ 22.97M |
| 2018 | $ 21.17M | $ -6.21M | $ -3.69M | $ 16.39M | $ 42.01M |
| 2017 | $ 9.45M | $ -3.74M | $ -4.32M | $ 3.74M | $ 3.22M |
| 2016 | $ 5.24M | $ 884.6K | $ 600.0K | $ 3.13M | $ 2.08M |
| 2015 | $ 4.76M | $ -4.48M | $ -703.8K | $ 2.68M | $ 844.2K |
| 2014 | $ 3.98M | $ -5.12M | $ -5.63M | $ 4.9K | $ 4.00M |
| 2013 | $ 1.56M | $ -2.18M | $ -1.37M | $ 543.9K | $ 5.92M |
| 2012 | $ 777.8K | $ -1.07M | $ -233.1K | $ 1.88M | $ 523.2K |
| 2011 | N/A | N/A | $ -186 | $ 0 | $ 391.6K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.49 |
| Liabilities / Eq | 1.97 |
| Current Ratio | 1.12 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 9.90 |

## Other views

- [Metrics](https://sponda.capital/en/MEDXF.md)
- [Charts](https://sponda.capital/en/MEDXF/charts.md)
- [Compare](https://sponda.capital/en/MEDXF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.